We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 10.00 (14.286%)
Open: 75.00
High: 75.00
Low: 75.00
Prev. Close: 75.00
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results

2 Mar 2023 07:00

RNS Number : 5852R
Fiske PLC
02 March 2023
 

02 March 2023

FISKE PLC

("Fiske" or the "Company" or the "Group")

Interim results

Fiske (AIM:FKE) is pleased to announce its interim results for the six months ended 31 December 2022.

 

In accordance with rule 26 of the AIM Rules for Companies this information is also available, under the Investors section, at the Company's website, http://www.fiskeplc.com .

 

For further information, please contact:

 

Fiske PLCJames Harrison (CEO) Tel: +44 (0) 20 7448 4700100 Wood Street

London

EC2V 7AN

Grant Thornton UK LLP (Nominated Adviser) Tel: +44 (0) 20 7383 5100Samantha Harrison / Harrison Clarke / Samuel Littler

 

Trading

 

Across the half year to December 2022 UK markets were broadly level, although there was a material dip in October. Meanwhile, across the world, different markets had separate distinctive profiles in the period. With Fiske's client assets invested internationally, assets under management and thus management fees were broadly level; slightly down versus the prior reported interims (to November 2021) but slightly up on the immediately preceding six months to 30 June 2022.

 

In contrast, commission revenues were some 15% lower than the prior reported interims (to November 2021) and also lower than the immediately preceding six months to 30 June 2022. We believe that this recent pattern reflects the apparent turmoil in the world, with sentiment highly tuned to expectations around interest rate movements.

 

In a period of double-digit inflation, operating expenses have increased by some 4% over the immediately preceding six months to June 30, but are down almost 10% on the prior reported interims (to November 2021) when we had the expenses associated with our relocation to new offices at 100 Wood Street and restructuring costs incurred in anticipation of a smaller office footprint. As expected, we now benefit from the reduction in overall property costs.

 

Overall, the profit before tax for the half year to 31 December 2022 was £28,000 compared to a loss of £6,000 in the half year to November 2021.

 

Our cash balances remain strong, at £3.1m.

 

Recent results from Euroclear showed further improvement in the company's operating businesses. Sales of shares by other shareholders have taken place at modestly lower levels than when last notified. Accordingly, we have adjusted our holding value down to this lower level. The company also guided shareholders that it expects to increase its dividend, payable in October 2023, by some 31%.

 

Significant regulatory change in the form of the Consumer Duty is due for implementation in 2023. Considerable time and effort is being spent evaluating how the new rules should be implemented across our business and client base. As guided by the Financial Conduct Authority we have appointed a Consumer Duty Champion at Board level to oversee the implementation of these new regulations.

 

Markets

 

Over the past six months market leadership has shifted dramatically away from highly valued US technology growth stocks and pandemic beneficiaries towards higher yielding value situations found in the "old economy" sectors that are so predominant in the UK equity market. The relatively low ratings of many of the UK's major companies are attracting the interest of activist investors. As a result, the US and UK markets have become disconnected with the latter moving ahead whilst the US market and the NASDAQ market are falling. Whilst not necessarily a long-term trend this adjustment may have further to go.

 

The two major factors affecting stock markets at present are the European war between Russia and Ukraine and the high level of inflation. It would appear that neither is about to be solved favourably in the short term. The Russian invasion of Ukraine and in the background the threatening behaviour of China towards Taiwan have at last so disturbed the very complacent Western powers that the geo-political scene for at least the next decade will be totally changed. 

 

Defence expenditure, for so long a declining priority amongst Western but especially European powers, has re-emerged as an urgent priority. At the same time inflation which has been quiescent for two decades has been rekindled partly by the changed world political scene but more because it had never gone away but rather lain dormant and consequently ignored. Commodity prices, especially that of oil and gas, have always been volatile but what we have seen in the past decade looks more like a major readjustment and as such will be of economic significance for many years to come. The idea that inflation in the West will return to a maximum of 2% within the current calendar year is naïve if not irresponsible and seems like the wish fulfilment of the Wall Street bulls rather than a considered economic forecast.

 

Outlook

 

History tells us that markets will eventually be calmer and meanwhile it is our role to focus on delivering the best investment strategies to protect and grow our client's assets. Since December 2022, we have executed an overhaul of our fee tariffs and are legislating for this to increase our income; a much-needed implementation given the ever-increasing costs, especially those pertaining to regulations and compliance.

 

 

Clive Fiske Harrison James P Q Harrison

Chairman Chief Executive Officer

02 March 2023

 

Condensed Consolidated Statement of Total Comprehensive Income

For the six months ended 31 December 2022

 

 

note

6 months ended

31 December 2022

Unaudited

6 months ended

30 November 2021

Unaudited

13 months ended

30 June 2022

Audited

£'000

 

£'000

 

£'000

 

Revenues

2

2,604

2,856

5,764

Operating expenses

(2,762)

(3,035)

(6,269)

Operating (loss)/profit

(158)

(179)

(505)

Investment revenue

200

183

185

Finance costs

(14)

(10)

(29)

Profit/(loss) on ordinary activities before taxation

28

(6)

(349)

Taxation credit/(charge)

-

-

177

Profit/(loss) on ordinary activities after taxation

28

(6)

(172)

Other comprehensive income/(expense)

Items that may subsequently be reclassified to profit or loss

Movement in unrealised appreciation of investments

(192)

(35)

1,017

Deferred tax on movement in unrealised appreciation of investments

3

48

(162)

 

(443)

Net other comprehensive income/(expense)

(144)

(197)

574

Total comprehensive income/(loss) for the period/year attributable to equity shareholders

(116)

(203)

402

Profit/(loss) Earnings per ordinary share (pence)

4

Basic

0.2p

(0.1)p

(1.5)p

Diluted

0.2p

(0.1)p

(1.5)p

 

 

All results are from continuing operations and are attributable to equity shareholders of the parent Company.

 

Condensed Consolidated Statement of Financial Position

31 December 2022

 

 

 

As at

31 December 2022

Unaudited

As at

30 November 2021

Unaudited

As at

30 June 2022

Audited

£'000

 

£'000

 

£'000

 

Non-current assets

Intangible assets arising on consolidation

830

1,050

911

Other intangible assets

-

16

-

Right-of-use assets

203

304

250

Property, plant and equipment

18

30

21

Investments held at Fair Value Through Other Comprehensive Income

4,429

3,568

4,621

Total non-current assets

5,480

4,968

5,803

Current assets

Trade and other receivables

2,417

2,797

2,450

Cash and cash equivalents

3,051

3,620

3,248

Total current assets

5,468

6,417

5,698

Current liabilities

Trade and other payables

1,801

2,647

2,147

Short-term lease liabilities

106

-

106

Current tax liabilities

-

43

-

Total current liabilities

1,907

2,690

2,253

Net current assets

3,561

3,727

3,445

Non-current liabilities

Long-term lease liabilities

111

308

155

Deferred tax liabilities

785

735

833

Total non-current liabilities

896

1,043

988

Net assets

8,145

7,652

8,260

Equity

Share capital

2,957

2,957

2,957

Share premium

2,085

2,085

2,085

Revaluation reserve

2,984

2,356

3,128

Retained earnings

119

254

90

Shareholders' equity

8,145

7,652

8,260

 

 

Condensed Consolidated Statement of Changes in Equity

For the six months ended 31 December 2022

 

 

Share Capital

Share Premium

Revaluation Reserve

Retained Earnings

Total Equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 July 2022

2,957

2,085

3,128

90

8,260

Profit on ordinary activities after taxation

-

-

-

28

28

Movement in unrealised appreciation of investments

-

-

(192)

-

(192)

Deferred tax on movement in unrealised appreciation of investments

-

-

48

-

48

Total comprehensive income / (expense) for the period

-

-

(144)

28

(116)

 

Share based payment transactions

-

-

-

1

1

Total transactions with owners, recognised directly in equity

-

-

-

1

1

Balance at 31 December 2022

2,957

2,085

2,984

119

8,145

 

Balance at 31 May 2021

2,939

2,082

2,553

562

8,136

Adjustments

-

-

-

(303)

(303)

Balance at 31 May 2020 as restated

2,939

2,082

2,553

259

7,833

(Loss) on ordinary activities after taxation

-

-

-

(6)

(6)

Movement in unrealised appreciation of investments

-

-

(35)

-

(35)

Deferred tax on movement in unrealised appreciation of investments

-

-

(162)

-

(162)

Total comprehensive income / (expense) for the period

-

-

(197)

(6)

(203)

 

Share based payment transactions

-

-

-

1

1

Issue of ordinary share capital

18

3

-

-

21

Total transactions with owners, recognised directly in equity

18

3

-

1

22

Balance at 30 November 2021

2,957

2,085

2,356

254

7,652

 

Balance at 1 June 2021

2,939

2,082

2,553

259

7,833

(Loss) on ordinary activities after taxation

-

-

-

(172)

(172)

Movement in unrealised appreciation of investments

-

-

1,017

-

1,017

Deferred tax on movement in unrealised appreciation of investments

-

-

(443)

-

(443)

Realised disposal of Fair Value through OCI

-

-

1

-

1

Total comprehensive income / (expense) for the period

-

-

575

(172)

403

 

Share based payment transactions

-

-

-

3

3

Issue of ordinary share capital

18

3

-

-

21

Total transactions with owners, recognised directly in equity

18

3

-

3

24

Balance at 30 June 2022

2,957

2,085

3,128

90

8,260

 

 

Condensed Consolidated Statement of Cash Flows

For the six months ended 31 December 2022

 

 

6 months ended

31 December 2022

Unaudited

6 months ended

30 November 2021

Unaudited

13 months ended

30 June 2022

Audited

£'000

 

£'000

 

£'000

 

Operating (loss)/profit

(158)

(179)

(505)

Amortisation of intangible assets arising on consolidation

81

80

218

Amortisation of other intangible assets

-

16

32

Depreciation of right-of-use assets

47

23

79

Depreciation of property, plant and equipment

6

15

31

Expenses settled by the issue of shares

1

1

3

Decrease/(increase) in receivables

683

(305)

248

(Decrease)/increase in payables

(996)

317

(389)

Cash generated (used in)/from operations

(336)

(32)

(283)

Tax recovered / (paid)

-

-

(49)

Net cash (used in)/generated from operating activities

(336)

(32)

(332)

Investing activities

Investment income received

200

183

185

Interest received

-

-

-

Purchases of property, plant and equipment

(3)

(21)

(28)

Purchases of other intangible assets

-

-

-

Net cash (used in)/ generated from investing activities

197

162

157

Financing activities

Interest paid

(14)

(10)

(29)

Proceeds from issue of ordinary share capital

-

22

22

Repayment of lease liabilities

(44)

(20)

(68)

Net cash used in financing activities

(58)

(8)

(75)

Net (decrease) / increase in cash and cash equivalents

(197)

122

(250)

Cash and cash equivalents at beginning of period

3,248

3,498

3,498

Cash and cash equivalents at end of period/year

3,051

3,620

3,248

 

 

Notes to the Interim Financial Statements

1.  Basis of preparation

The Condensed Consolidated Interim Financial Statements of Fiske plc and its subsidiaries (the Group) for the six months ended 31 December 2022 have been prepared in accordance with IAS 34 (Interim Financial Reporting), as adopted in the United Kingdom. The accounting policies applied are consistent with those set out in the June 2022 Fiske plc Annual Report and accounts. These Condensed Consolidated Interim Financial Statements do not include all the information required for full annual statements and should be read in conjunction with the June 2022 Annual Report and Accounts.

The Financial Statements of the Group for the 13-month period ended 30 June 2022 were prepared in accordance with International Financial Reporting Standards adopted by in the United Kingdom. The statutory Consolidated Financial Statements for Fiske plc in respect of the 13-month period ended 30 June 2022 have been reported on by the Company's auditor and delivered to the registrar of companies. The report of the auditor was (i) unqualified, (ii) did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006.

Under IAS 27 these financial statements are prepared on a consolidated basis where the Group consists of Fiske plc, the parent, and those subsidiaries in which it owns 100% of the voting rights, being Ionian Group Limited, Fiske Nominees Limited, Fieldings Investment Management Limited and VOR Financial Strategy Limited.

 

The directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing this half-yearly financial report.

There were no new mandatory standards or amendments to existing standards effective in the six-month reporting period to 31 December 2022.

 

2.  Revenues

IFRS 8 requires operating segments to be identified on the basis of internal reports about components of the Group that are regularly reviewed by management to allocate resources to the segments and to assess their performance. Following the acquisition of Fieldings Investment Management Limited in August 2017, their staff and operations have been integrated into the management team of Fiske plc. Pursuant to this, the Group continues to identify a single reportable segment, being UK-based financial intermediation. Within this single reportable segment, total revenue comprises:

 

 

 

6 months ended

31 December 2022

Unaudited

6 months ended

30 November 2021

Unaudited

13 months ended

30 June 2022

Audited

£'000

£'000

£'000

Commission receivable

1,087

1,276

2,576

Investment management fees

1,495

1,578

3,186

 

2,582

2,854

5,762

Other income

22

2

2

 

2,604

2,856

5,764

 

 

3.  Deferred tax

Deferred tax assets and liabilities are recognised at a rate which is substantively enacted at the balance sheet date. The rate to be taken in this case is 25%, (13 months to June 2022: 25%) being the anticipated rate of taxation applicable to the Group and Company in the following year.

 

4.  Earnings per share

 

 

 

Basic

Diluted

Basic

£'000

£'000

Profit on ordinary activities after taxation

28

28

Adjustment to reflect impact of dilutive share options

-

-

Profit

28

28

Weighted average number of shares (000's)

11,830

11,830

Profit per share (pence)

0.2p

0.2p

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFLTVDILIIV
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.